Skip to Content
Colorado Attorney General

Phil Weiser

Colorado Attorney General

File A Complaint
  • About Us
    • Attorney General Bio & Photos
    • Vision & Values
    • Senior Staff & Organization
    • Colorado Attorney General Annual Report
    • Attorney General Opinions
    • Contact Our Office
  • Sections
    • Administration
    • Business & Licensing
    • Civil Litigation & Employment Law
    • Consumer Protection
    • Criminal Appeals
    • Criminal Justice
    • Natural Resources & Environment
    • Division of Community Engagement
    • Revenue & Utilities
    • State Services
  • Careers
    • Attorney & Other Non-Classified Positions
    • Fellowships
    • Internships
    • Classified Staff Positions
    • Other Opportunities to Join our Team
  • Media Center
    • Press Room
    • Colorado Open Records Act – CORA
  • Resources
    • Survivors of Childhood Sexual Abuse
    • Victim Assistance
    • Budget & Accounting
    • Colorado Privacy Act
    • Code of Colorado Regulations
    • Colorado Revised Statutes
    • Coronavirus Information
    • Data Protection Laws
    • Funding Opportunities
    • Office of Financial Empowerment
    • Student Loans
    • Transparency Online Project (TOPS)
  • Licensing
    • Business Resources
    • Collection Agencies & Debt Collectors
    • Colorado Uniform Consumer Credit Code: Licensing & Notification
    • Debt Management Services Providers
    • Health Club Bonds
    • Repossessors
    • Student Loan Servicers: Licensing
    • Telemarketing
  • Recursos en español

Colorado to receive more than $2.6 million in settlement with surgical mesh manufacturer Boston Scientific Corporation

March 24, 2021–Attorney General Phil Weiser today announced Colorado will receive $2,606,605 in a multistate settlement with Boston Scientific Corporation for the deceptive marketing of its surgical mesh products for women.

The settlement, which was reached between the attorneys general of 47 states and the District of Columbia and the company, requires a total payment of $188.6 million. The attorneys general alleged that Boston Scientific deceptively marketed transvaginal surgical mesh devices to patients by failing to disclose the full range of potential serious and irreversible complications caused by mesh, including chronic pain, new onset of incontinence, and other complications.

“The deceptive practices of this irresponsible company impacted thousands of women, who now face lifelong complications,” said Weiser. “By requiring marketing, training, and clinical trial reforms in this settlement, we will help ensure that the company will be transparent and no longer cause women such harm.”

Surgical mesh is a synthetic woven fabric that is implanted in the pelvic floor through the vagina to treat common health conditions in women such as stress urinary incontinence and pelvic organ prolapse. These are common conditions faced by women due to a weakening in their pelvic floor muscles caused by childbirth, age, or other factors. Although use of surgical mesh involves the risk of serious complications and is not proven to be any more effective than traditional tissue repair, millions of women were implanted with the devices and thousands of women are alleged to have suffered serious complications resulting from these devices.

Under the terms of the settlement, Boston Scientific is required to cease deceptive marketing practices and implement training and clinical trial reforms, including the following:

Marketing reforms:

  • For marketing materials intended for consumers, describe complications in understandable terms;
  • For certain marketing materials, disclose significant complications, including the inherent risks of mesh;

Training reforms:

  • Inform healthcare providers of significant complications when providing training regarding procedures for insertion and implantation;
  • Maintain policies requiring that its independent contractors, agents, and employees who sell, market, or promote mesh are adequately trained to report patient complaints and adverse events to the company;

Clinical trial reforms:

  • When submitting a clinical study or clinical data regarding mesh for publication, disclose the company’s role as a sponsor and any author’s potential conflict of interest;
  • Refrain from citing any clinical study, clinical data, preclinical data, research, or article regarding mesh for which the company has not complied with the disclosure requirements in the injunction; and
  • Register all Boston Scientific-sponsored clinical studies regarding mesh with ClinicalTrials.gov.

The money from the settlement will be used for reimbursement of the State’s actual costs and attorneys’ fees, and for future consumer fraud or antitrust enforcement, consumer education, or public welfare purposes.

###

Media Contact:
Lawrence Pacheco
Director of Communications
(720) 508-6553 office | (720) 245-4689 cell
Lawrence.pacheco@coag.gov

Most Recent

Attorney General Phil Weiser calls SCOTUS abortion ruling “a momentous mistake,” reaffirms his commitment to steadfastly defend the Colorado Reproductive Health Equity Act

June 24, 2022 (DENVER)—Colorado Attorney General Phil Weiser released the following statement regarding the U.S. Supreme Court’s decision upending the right to access abortion care in Dobbs v. Jackson Women’s Health Organization: “Today, the U.S. Supreme Court overturned 50 years […]

Statement of Attorney General Phil Weiser on FDA's decision to order JUUL to stop selling e-cigarettes

June 23, 2022 (DENVER)—Attorney General Phil Weiser released the following statement regarding the Food and Drug Administration’s decision to order JUUL to stop selling e-cigarettes on the U.S. market: “As Colorado’s lawsuit against JUUL demonstrates, the company and its founders […]

Red Rocks Credit Union returns more than $300,000 in GAP refunds to Colorado consumers

June 23, 2022 (DENVER) – Attorney General Phil Weiser today announced that Red Rocks Credit Union refunded Coloradans more than $300,000 after the credit union failed to return money consumers were entitled to under state law for unearned guaranteed automobile […]

Office of the Attorney General
Colorado Department of Law
Ralph L. Carr Judicial Building
1300 Broadway, 10th Floor
Denver, CO 80203

(720) 508-6000

Contact the Office of the Attorney General

Contact

Facebook
Twitter